Patient Story
Saved by his stem cells
At age 17, Joshua Do had never heard of Ewing sarcoma—or the promising treatment known as autologous stem cell transplant.
At age 17, Joshua Do had never heard of Ewing sarcoma—or the promising treatment known as autologous stem cell transplant.